Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01002287 · ClinicalTrials.gov registry record · NA
An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery
A NA study, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01002287 is a NA study that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 11 participants.
The verdict
NCT01002287, a NA study, was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This will be a prospective, multi-center, randomized, single blind study to collect and evaluate post-market clinical data on the SprayShield Adhesion Barrier System as an adjuvant to good surgical technique for the reduction of postoperative adhesion formation following major open abdominal surgery.
Interventions
- DEVICE SprayShield Adhesion Barrier System
- PROCEDURE Good Surgical Technique Alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01002287
The ClinicalTrials.gov registry entry for NCT01002287 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SprayShield Adhesion Barrier System is the first listed.
NCT01002287 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01002287 about?
NCT01002287 is a clinical study titled "An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery". This will be a prospective, multi-center, randomized, single blind study to collect and evaluate post-market clinical data on the SprayShield Adhesion Barrier System as an adjuvant to good surgical technique for the reduction of postoperative adhesion formation following major open abdominal surgery...
What is the current status of trial NCT01002287?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2009-10. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01002287?
The interventions under investigation include: SprayShield Adhesion Barrier System (DEVICE), Good Surgical Technique Alone (PROCEDURE).
Who is sponsoring clinical trial NCT01002287?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.